Skip to main content

Advertisement

SpringerLink
Log in

Clinical use of dopamine transporter imaging in movement disorders: benefits of appropriate use

  • Focus on
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, et al. Role of DAT-SPECT in the diagnostic work up of Parkinsonism. Mov Disord 2007;22(9):1229–38. Jul 15.

    Article  PubMed  Google Scholar 

  2. Vlaar AM, van Kroonenburgh MJ, Kessels AG, Weber WE. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol. 2007 Sep 1;7:27. DOI 10.1186/1471–2377–7–27.

  3. Vlaar AM, de Nijs T, Kessels AG, Vreeling FW, Winogrodzka A, Mess WH, et al. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes. Eur Neurol 2008;59(5):258–66. Feb 8.

    Article  PubMed  Google Scholar 

  4. Weber WE, Vlaar AM. Role of DAT-SPECT in diagnostic work-up of Parkinsonism. Mov Disord. 2008 Feb 8. DOI 10.1002/mds.21952.

  5. Scherfler C, Poewe W. Reply: Role of DAT SPECT in the diagnostic work-up of Parkinsonism. Mov Disord. 2008 Feb 28; DOI 10.1002/mds.21947.

  6. Tolosa E, Borght TV, Moreno E. DaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov Disord 2007;22(16):2346–51. Dec.

    Article  PubMed  Google Scholar 

  7. Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 2007;78(11):1176–81. Nov.

    Article  PubMed  Google Scholar 

  8. Booij J, Kemp P. Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging 2008;35(2):424–38. Feb.

    Article  PubMed  CAS  Google Scholar 

  9. Newberg A, Lerman C, Wintering N, Ploessl K, Mozley PD. Dopamine transporter binding in smokers and nonsmokers. Clin Nucl Med 2007;32(6):452–5. Jun.

    Article  PubMed  Google Scholar 

  10. Chen PS, Yang YK, Yeh TL, Lee IH, Yao WJ, Chiu NT, et al. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers-A SPECT study. Neuroimage 2008;40(1):275–9. Mar 1.

    Article  PubMed  Google Scholar 

  11. Varrone A, Sansone V, Pellecchia MT, Amboni M, Salvatore E, De Michele G, et al. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. Eur J Nucl Med Mol Imaging. 2008 Feb 19; [Epub ahead of print]. DOI 10.1007/s00259–008–0729-x.

  12. Zaknun JJ, Schucktanz H, Aichner F. Impact of instrumentation on DaTSCAN imaging: how feasible is the concept of cross-systems correction factor? Q J Nucl Med Mol Imaging 2007;51(2):194–203. Jun.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Radiological Sciences, University of Milan, Unit of Nuclear Medicine, Hospital San Paolo Via Antonio di Rudinì, 8, 20142, Milan, Italy

    Giovanni Lucignani

Authors
  1. Giovanni Lucignani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Lucignani.

Additional information

“Focus on…” commentaries aim to highlight only papers published within the past year and draw extensively on the texts and summaries of the articles referenced.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucignani, G. Clinical use of dopamine transporter imaging in movement disorders: benefits of appropriate use. Eur J Nucl Med Mol Imaging 35, 1213–1217 (2008). https://doi.org/10.1007/s00259-008-0792-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-0792-3

Keywords

Search

Navigation